Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial-Reference-Cited by-同舟云学术

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

Published:2011-12 Issue:9807 Volume:378 Page:1931-1939
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rini Brian I,Escudier Bernard,Tomczak Piotr,Kaprin Andrey,Szczylik Cezary,Hutson Thomas E,Michaelson M Dror,Gorbunova Vera A,Gore Martin E,Rusakov Igor G,Negrier Sylvie,Ou Yen-Chuan,Castellano Daniel,Lim Ho Yeong,Uemura Hirotsugu,Tarazi Jamal,Cella David,Chen Connie,Rosbrook Brad,Kim Sinil,Motzer Robert J

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Renal-cell carcinoma;Motzer;N Engl J Med,1996

2. Metastatic renal cell carcinoma: many treatment options, one patient;Rini;J Clin Oncol,2009

3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

4. Sorafenib in advanced clear-cell renal-cell carcinoma;Escudier;N Engl J Med,2007

5. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial;Sternberg;J Clin Oncol,2010

Cited by 1634 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy;Current Treatment Options in Oncology;2024-09-11

2. The treatment of metastatic renal cell carcinoma;Deutsches Ärzteblatt international;2024-08-23

3. Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology;Current Oncology;2024-08-22

4. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma;New England Journal of Medicine;2024-08-22

5. Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT;Health Technology Assessment;2024-08